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Background: Several studies sustain the modulator role of MBL gene on CF
pulmonary status. MBL protein is an important factor of the innate immune system
that activates complement and opsonisation. Therefore the deﬁcit of MBL can
predispose to numerous respiratory infections and deterioration of pulmonary con-
dition. Purpose of study was to determine the relation between patient’s pulmonary
status and MBL serum levels.
Methods: Twenty-three children with age between 6−18 years, DF508 homozy-
gous were tested for MBL protein deﬁciency. Patients were evaluated by clinical
assessment, bacteriological exam and spirometry at last annual evaluation.
Results: Among patients with severe pulmonary status (26%) an important part
(83% of them) associated low MBL serum levels, while in children with good
pulmonary condition only 14.2% were MBL deﬁcient. Relative risk that MBL
deﬁcient patient develop severe lung disease is six time superior by comparison
to patients with normal MBL.
Conclusions:MBL deﬁciency is a risk factor for severe lung disease in CF children.
The increase predisposition for pulmonary infection among MBL deﬁcient patient
could be the reason.
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In the last decades numerous scientists pull out sputum investigation as a tool that
could be as informative as and more suitable than examination of broncho-alveolar
lavage.
We investigated 12 patents with cystic ﬁbrosis (5 girls and 7 boys, aged from 7 to
17 years of age), admitted in the Pediatric clinic for exacerbation more than one
time for the last 4 years. The patients expectorated simultaneously and the sputum
was collected and studied cytologically and microbiologically. We compared the
results from different hospitalisations for each patient.
All the patients were infected with Pseudomonas aeruginosa. In 9 patients neutroﬁl
levels are higher in the second admission, which could be explained with the
progressive evolution of the disease. In one patient the difference in the neutroﬁl
level between the two hospitalizations is less than 5%. Two of the patients had
signiﬁcant reduction in the neutroﬁl count. This was probably due to the difference
in the Pseudomonas strains found out – both of the patients had strain with genes
for producing neuroaminidase in the ﬁrst admission, and strains with no such genes
in the second.
Metaplasia in the epithelial cells was found almost in all of the patients, and in 1/3
of them had lower metaplasia percentage in the second admission, which could be
connected with the natural history and progression of the disease, but this should
be conﬁrmed with further investigations.
Conclusion: Early determination of the endobronchial inﬂammation in CF patients
is extremely important for the bacterial infection leads to progressive lung damage
long before objective drop in the functional parameters during spirometry test.
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Background: In Cystic Fibrosis several independent predictors of morbidity and
mortality have been proposed, but the strongest predictor of mortality is considered
to be baseline lung function below 30% predicted (Kerem, 1992). In order to identify
early those patients at risk from a rapidly declining lung function and clinical status
it was decided to evaluate an early warning score (EWS) based on some respiratory
independent predictors of morbidity and mortality.
Objective: The aim of this study was to evaluate the effectiveness of an early
warning score on FEV1 decline and mortality 1 year later.
Methods: A retrospective analysis of 140 adult CF patients was conducted. Patients
were scored between 0–27 based on baseline and annual decline in lung function,
microbiological status, number of IVs/annum, compliance and complications (pneu-
mothorax and haemothorax) at annual review between Jan 2005–2006. The higher
the EWS score the greater the clinical concern. The FEV1 decline rate and mortality
were assessed one year later.
Statistical Analysis: Statistical analysis included Pearson’s correlation to examine
any relationship between FEV1 decline and EWS and spearman’s rank rho for any
relationship between number of IV antibiotics and EWS. The Mann Whitney U test
to assess any difference between those who died (n = 3) and those who survived
(n = 137) in relation to early warning score.
Results: The EWS signiﬁcantly correlated (r = 0.59 p< 0.05) with number of IVs
but no other independent variable. Patients who died tended to score higher but this
did not reach signiﬁcance.
Conclusion: We were unable to demonstrate any beneﬁt of the EWS over FEV1
on mortality in this study. However, patients with high EWS may beneﬁt from
additional MDT input to reduce the number of exacerbations.
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Isolation of pathogens is central to the appropriate management of respiratory
disease in CF. For non expectorating patients; the most common method for
obtaining samples has been the cough swab. Cough plates were introduced in to our
CF clinics in March 2006 as an alternative and potentially more effective method of
sample collection. Cough swabs continued to be used in the ward and community
settings.
The aim of this audit was to assess the frequency of positive cultures on cough
plates and to determine whether this was comparable to rates previously achieved
using cough swabs alone in non expectorating patients aged 3 years and over. Data
was audited from March 2005 to February 2006 (Year 1) when cough swabs alone
were used and compared to March 2006–February 2007 (Year 2) when both cough
swabs and cough plates were in use.
Results: 823 cough swabs were taken in Year 1 compared to a total of 782 cough
swabs and cough plates in Year 2 (404 cough swabs, 378 cough plates). Positive
cultures were obtained in 20% of samples in Year 1 and 18% in Year 2 (cough
swabs 20%, cough plates 14%). These are presented in the table. There was no
overall decrease in the isolation of pathogens in the year following introduction of
cough plates.
Conclusion: Introduction of cough plates has not led to any apparent deterioration
in standards. However, a large scale study is needed to determine the appropriate
use of this method of sample collection and this is currently in progress.
Pathogen Year 1 Year 2 C swabs (yr 2) c plates (yr 2)
P. aeruginosa 46 58 30 28
Staph aureus 11 7 4 3
H. inﬂuenza 10 17 10 7
Aspergillus 7 4 3 1
B. cepacia 2 0 0 0
